Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

New treatments for PCOS focus on managing symptoms and improving fertility.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Early diagnosis and personalized treatment are crucial for managing different types of alopecia effectively.

Scalp fungus infections in Spain are a health concern, with changing causes and a need for better treatment and prevention.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Gray hair regained color after thyroid hormone treatment.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Covers common skin issues in kids, their diagnosis, treatment, and need for specialist care.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

Indian jujube has many medicinal properties and can help treat ailments like diabetes, inflammation, and cancer.

Human hair is a significant sample for various tests in clinical, nutritional, archaeological, and forensic studies.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.